mRNA vaccines: Overview
What it does
The job the technology does for people, in a short paragraph
An mRNA vaccine trains the immune system by giving cells the instructions to make one harmless protein of a germ, instead of the germ itself. The first two were approved against COVID-19 in December 2020 [1]. More than 13 billion COVID-19 vaccine doses of all types, mRNA and others, had been given by 2023 [1].
as of 2026-11-11
How it works
The working principle in plain words, step by step
Cells use messenger RNA, a short-lived copy of a gene, as a template for making proteins [1]. An mRNA vaccine contains an mRNA that codes for one protein from the surface of a virus. The mRNA is made in a tank by enzymes copying a DNA template, without growing any cells [2]. Its building blocks are slightly changed so the body does not treat it as an invader and set off inflammation [1]. The mRNA is wrapped in tiny fat droplets, lipid nanoparticles, which protect it and carry it into cells [3]. After the injection, cells read the message, make the protein and show it to the immune system, which makes antibodies and memory cells. The mRNA itself is short-lived and soon breaks down.
as of 2026-11-11
Key figures
The handful of numbers that size it up, each with its unit, year and source
| Figure | Value | Unit | Year | Source |
|---|---|---|---|---|
| COVID-19 vaccine doses given worldwide, all types (not only mRNA), more than | 13 | billion doses | 2023 | [1] |
| Pfizer's reported revenue from Comirnaty, its mRNA vaccine (direct sales and alliance revenues) | 37,806 | million USD | 2022 | [5] |
| Pfizer's reported total revenue | 100,330 | million USD | 2022 | [5] |
| Years from the key finding on modified mRNA to approval | 15 | years | 2020 | [1] |
as of 2026-11-11. The dose count covers all COVID-19 vaccines, not only mRNA ones; it comes from the Nobel announcement of October 2023, so 2023 is the publication year, not a data year [1]. The revenue figures are Pfizer's own; about 38% of its 2022 revenue came from the vaccine (calculated: 37,806 / 100,330).
Where it is used
The main places and products the technology is found in
- COVID-19 vaccines, approved from December 2020 [1]
- National immunisation programmes and mass vaccination centres
- Clinics and pharmacies giving booster doses
- Research on vaccines against other infections and on cancer treatments [2]
as of 2026-11-11
Scale today
How much of it there is now: units in use, made each year and who uses it
- Made per year
- No count of mRNA doses alone was found; more than 13 billion COVID-19 doses of all types had been given by 2023 [1]
- Unit
- doses
- Year
- 2023
- Note
- The count is for all COVID-19 vaccines, so it is an upper bound for mRNA vaccines; 2023 is the year of the Nobel announcement that gives it.
as of 2026-11-11
Sources
- Press release: The Nobel Prize in Physiology or Medicine 2023 The Nobel Assembly at Karolinska Institutet, 2023
- mRNA vaccines - a new era in vaccinology Nature Reviews Drug Discovery (N. Pardi, M. J. Hogan, F. W. Porter and D. Weissman), 2018
- The tangled history of mRNA vaccines Nature 597, 318 to 324 (Elie Dolgin), 2021
- Financial Performance (Pfizer 2022 Annual Review) Pfizer